Strs Ohio Protagonist Therapeutics, Inc Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Strs Ohio holds 21,500 shares of PTGX stock, worth $874,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,500

Previous 24,900 13.65%

Holding current value

$874,835

Previous $862,000 12.06%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$33.72 - $47.33 $114,648 - $160,922	-3,400 Reduced 13.65%	21,500 $966,000
Q2 2024 Aug 05, 2024	BUY	$24.66 - $34.8 $567,180 - $800,399	23,000 Added 1210.53%	24,900 $862,000
Q1 2024 May 13, 2024	SELL	$21.79 - $32.15 $10,895 - $16,075	-500 Reduced 20.83%	1,900 $54,000
Q4 2023 Jan 30, 2024	SELL	$14.05 - $23.44 $134,880 - $225,024	-9,600 Reduced 80.0%	2,400 $55,000
Q3 2023 Oct 26, 2023	SELL	$16.68 - $23.66 $195,156 - $276,822	-11,700 Reduced 49.37%	12,000 $200,000
Q2 2023 Jul 31, 2023	BUY	$18.02 - $29.36 $427,074 - $695,832	23,700 New	23,700 $654,000
Q1 2023 Aug 02, 2023	BUY	$10.78 - $25.38 $51,744 - $121,824	4,800 Added 20.25%	28,500 $655,000
Q2 2022 Jul 25, 2022	BUY	$7.06 - $25.52 $18,356 - $66,352	2,600 Added 20.47%	15,300 $121,000
Q1 2022 Apr 21, 2022	SELL	$23.34 - $36.08 $11,670 - $18,040	-500 Reduced 3.79%	12,700 $300,000
Q3 2021 Oct 22, 2021	BUY	$12.95 - $49.69 $56,980 - $218,636	4,400 Added 50.0%	13,200 $233,000
Q2 2021 Jul 26, 2021	SELL	$25.57 - $44.88 $30,684 - $53,856	-1,200 Reduced 12.0%	8,800 $394,000
Q4 2020 Jan 25, 2021	BUY	$18.49 - $25.13 $184,899 - $251,300	10,000 New	10,000 $201,000
Q3 2020 Dec 14, 2020	SELL	$15.19 - $22.4 $300,762 - $443,520	-19,800 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$6.19 - $18.84 $13,618 - $41,448	2,200 Added 12.5%	19,800 $349,000
Q4 2019 Jan 24, 2020	BUY	$4.69 - $13.45 $82,544 - $236,720	17,600 New	17,600 $124,000
Q2 2018 Aug 06, 2018	SELL	$5.99 - $9.1 $82,662 - $125,580	-13,800 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$8.46 - $23.08 $96,444 - $263,112	11,400 Added 475.0%	13,800 $118,000
Q3 2017 Oct 23, 2017	BUY	$10.61 - $17.98 $25,464 - $43,152	2,400	2,400 $42,000

Others Institutions Holding PTGX

# of Institutions

247

Shares Held

56.4M

Call Options Held

76.3K

Put Options Held

114K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account